Qui sommes-nous ? About us
L'ANSM en bref
About us
Nos engagements
Nos missions
Notre périmètre
Notre organisation
Déontologie et transparence
Publications institutionnelles
Rejoignez-nous !
Notre agenda
 
Bulletin officiel des actes, décisions et avis
Décisions institutionnelles
Décisions liées aux médicaments
Décisions liées aux produits sanguins et autres produits biologiques
Décisions liées aux médicaments dérivés du plasma
Décisions liées aux dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Injonctions
Décisions de police sanitaire
Sanctions financières
Avis
 
Disponibilité des produits de santé
Médicaments
Dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
 
Vos démarches
Industriel
Organismes notifiés
Professionnel de santé
Patient
Chercheur
 
Expertises et publications scientifiques
Rapports d'enquêtes de vigilance
Publications scientifiques

IncreaseNET X EU Innovation Network 2026 Innovation & Competitiveness Summit

A+ A-

On 15 October 2026, ANSM will host the IncreaseNET X EU Innovation Network 2026 Innovation & Competitiveness Summit, bringing together around a hundred representatives of national and European authorities, stakeholders in clinical research, representatives from academia and SMEs, as well as research funding bodies.

The event is co-organised by the Joint Action IncreaseNET and the EU Innovation Network (EU-IN), a joint EMA/HMA working group bringing together the competent national authorities and the EMA.

The aim of this day is to continue discussions on how to strengthen Europe's attractiveness and competitiveness in the field of health innovation, in particular by improving the support provided to innovative project leaders. The discussions will focus in particular on:
  • European competitiveness and developments in the regulatory framework;
  • The organisation and funding of clinical research;
  • The coordination and complementarity of the network with national and European support schemes for innovation in SMEs and academia, and the diversity of the offering (national and European scientific advice, support from innovation offices, etc.).
Program
  • An introduction featuring
    • Catherine Paugam-Burtz, Director General of ANSM,
    • Momir Radulović, Director General of the Slovenian Agency (JAZMP),
    • Emmanuel Cormier, Director of Regulatory Science and Innovation at the European Medicines Agency (EMA).
  • Three sessions 
    • Europe's positioning in terms of competitiveness and attractiveness,
    • Introduction to the clinical trials landscape in France,
    • The range of services supporting innovation in Europe and in the Member States.
  • A keynote dedicated to gene therapies, cell therapies and transplantation.
  • The day will conclude with a round table devoted to one central question: "How can we make the European innovation support offering more accessible and easier to navigate for project leaders?"
Attend the webinar
You can follow the webinar via the following link: https://zoom.us/j/95845163677?pwd=iCzQtFkJ8FBXc89E8QQrDJ6bKjTlpS.1
  • Webinar ID : 958 4516 3677
  • Passcode : 072980
15 oct. 2026
9:00 am - 5:15 pm